{ event: "article_read", name: `New horizon of RSV lower respiratory tract disease LRTD in infants: Reflection on two seasons of prevention`, author: ``, tags: `RSV`, publication_date: ``, interaction_type: "content" }
New horizon of RSV lower respiratory tract disease LRTD in infants: Reflection on two seasons of prevention
The symposium explored the latest real-world evidence and the evolving landscape of universal immunoprophylaxis for preventing RSV Lower Respiratory Tract Disease (LRTD) in infants. Key topics included current prevention strategies, direct experiences of local implementation approaches—especially for infants born outside RSV season—and the impact of RSV immunization programs on public health systems.
PANEL DISCUSSION
Burden of RSV disease in infants / Juan Pablo Torres (Chile)
Strategies and recommendations for RSV LRTD prevention for infants / Irene Rivero Calle (Spain)
Real-world evidence on impact:reflection on two seasons of prevention /Chiara Azzari (Italy)
Juan Pablo Torres (Chile)
Universidad de Chile
Pediatry and infectious disease
Irene Rivero-Calle (Spain)
Hospital Clinico Universitario de Santiago de Compostela
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website. Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.